Home › NDC Lookup › Labelers › Cycle Pharmaceuticals Ltd

Cycle Pharmaceuticals Ltd NDCs and Package Codes

This page lists NDC package records associated with labeler code 70709 (Cycle Pharmaceuticals Ltd) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

20
Package NDCs
23
Products
23
Active listings
0
Discontinued
8
Ingredients
0
Therapeutic classes
5
Dosage forms
0
With NADAC pricing

Portfolio

Top ingredients
dasatinib 6
Nitisinone 4
Fingolimod Lauryl Sulfate 4
Nilotinib 4
tiopronin 2
ICATIBANT 1
Dichlorphenamide 1
Penicillamine 1
By dosage form
TABLET 11
TABLET, ORALLY DISINTEGRATING 8
TABLET, DELAYED RELEASE 2
INJECTION 1
CAPSULE 1

Browse records — 23 products

Drug / product Billing NDC NADAC / unit Status
AAGYLUR Penicillamine 250 mg/1 CAPSULE Cycle · NDC 70709-0102-10 · 100 CAPSULE in 1 BOTTLE (70709-102-10) 70709-0102-10 — On market View →
CAVHANZA Nilotinib 60 mg/1 TABLET, ORALLY DISINTEGRATING Cycle · NDC 70709-0191-12 · 112 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (70709-191-12) 70709-0191-12 — On market View →
CAVHANZA Nilotinib 80 mg/1 TABLET, ORALLY DISINTEGRATING Cycle · NDC 70709-0192-12 · 112 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (70709-192-12) 70709-0192-12 — On market View →
CAVHANZA Nilotinib 60 mg/1 TABLET, ORALLY DISINTEGRATING Cycle · NDC 70709-0191-12 · 112 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (70709-191-12) 70709-0191-12 — On market View →
CAVHANZA Nilotinib 80 mg/1 TABLET, ORALLY DISINTEGRATING Cycle · NDC 70709-0192-12 · 112 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (70709-192-12) 70709-0192-12 — On market View →
HARLIKU nitisinone 2 mg/1 TABLET Cycle · NDC 70709-0112-60 · 1 BOTTLE, PLASTIC in 1 CARTON (70709-112-60) / 60 TABLET in 1 BOTTLE, PLASTIC 70709-0112-60 — On market View →
NITYR Nitisinone 10 mg/1 TABLET Cycle · NDC 70709-0000-60 · 1 BOTTLE, PLASTIC in 1 CARTON (70709-000-60) / 60 TABLET in 1 BOTTLE, PLASTIC 70709-0000-60 — On market View →
NITYR Nitisinone 5 mg/1 TABLET Cycle · NDC 70709-0005-60 · 1 BOTTLE, PLASTIC in 1 CARTON (70709-005-60) / 60 TABLET in 1 BOTTLE, PLASTIC 70709-0005-60 — On market View →
NITYR Nitisinone 2 mg/1 TABLET Cycle · NDC 70709-0002-60 · 1 BOTTLE, PLASTIC in 1 CARTON (70709-002-60) / 60 TABLET in 1 BOTTLE, PLASTIC 70709-0002-60 — On market View →
ORMALVI Dichlorphenamide 50 mg/1 TABLET Cycle · NDC 70709-0085-10 · 100 TABLET in 1 BOTTLE (70709-085-10) 70709-0085-10 — On market View →
PHYRAGO dasatinib 140 mg/1 TABLET Cycle · NDC 70709-0156-14 · 30 TABLET in 1 BOTTLE (70709-156-14) 70709-0156-14 — On market View →
PHYRAGO dasatinib 70 mg/1 TABLET Cycle · NDC 70709-0153-70 · 60 TABLET in 1 BOTTLE (70709-153-70) 70709-0153-70 — On market View →
PHYRAGO dasatinib 20 mg/1 TABLET Cycle · NDC 70709-0151-20 · 60 TABLET in 1 BOTTLE (70709-151-20) 70709-0151-20 — On market View →
PHYRAGO dasatinib 50 mg/1 TABLET Cycle · NDC 70709-0152-50 · 60 TABLET in 1 BOTTLE (70709-152-50) 70709-0152-50 — On market View →
PHYRAGO dasatinib 80 mg/1 TABLET Cycle · NDC 70709-0154-80 · 30 TABLET in 1 BOTTLE (70709-154-80) 70709-0154-80 — On market View →
PHYRAGO dasatinib 100 mg/1 TABLET Cycle · NDC 70709-0155-10 · 30 TABLET in 1 BOTTLE (70709-155-10) 70709-0155-10 — On market View →
SAJAZIR ICATIBANT 30 mg/3mL INJECTION Cycle · NDC 70709-0013-01 · 1 SYRINGE, GLASS in 1 CARTON (70709-013-01) / 3 mL in 1 SYRINGE, GLASS 70709-0013-01 — On market View →
TASCENSO ODT Fingolimod Lauryl Sulfate .5 mg/1 TABLET, ORALLY DISINTEGRATING Cycle · NDC 70709-0065-30 · 3 BLISTER PACK in 1 CARTON (70709-065-30) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK 70709-0065-30 — On market View →
TASCENSO ODT Fingolimod Lauryl Sulfate .25 mg/1 TABLET, ORALLY DISINTEGRATING Cycle · NDC 70709-0062-30 · 3 BLISTER PACK in 1 CARTON (70709-062-30) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK 70709-0062-30 — On market View →
TASCENSO ODT Fingolimod Lauryl Sulfate .25 mg/1 TABLET, ORALLY DISINTEGRATING Cycle · NDC 70709-0062-30 · 3 BLISTER PACK in 1 CARTON (70709-062-30) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK 70709-0062-30 — On market View →
TASCENSO ODT Fingolimod Lauryl Sulfate .5 mg/1 TABLET, ORALLY DISINTEGRATING Cycle · NDC 70709-0065-30 · 3 BLISTER PACK in 1 CARTON (70709-065-30) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK 70709-0065-30 — On market View →
VENXXIVA tiopronin 100 mg/1 TABLET, DELAYED RELEASE Cycle · NDC 70709-0121-30 · 300 TABLET, DELAYED RELEASE in 1 BOTTLE (70709-121-30) 70709-0121-30 — On market View →
VENXXIVA tiopronin 300 mg/1 TABLET, DELAYED RELEASE Cycle · NDC 70709-0123-90 · 90 TABLET, DELAYED RELEASE in 1 BOTTLE (70709-123-90) 70709-0123-90 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.